Prime Medicine Inc’s recent filing unveils that its 10% Owner Liu David R. acquired Company’s shares for reported $33590.0 on Jun 11 ’25. In the deal valued at $1.60 per share,21,000 shares were bought. As a result of this transaction, Liu David R. now holds 20,177,945 shares worth roughly $29.46 million.
Then, Brudnick Richard bought 20,000 shares, generating $23,790 in total proceeds. Upon buying the shares at $1.19, the Chief Business Officer now owns 20,000 shares.
Before that, LEE ANN L. bought 100,000 shares. Prime Medicine Inc shares valued at $113,000 were divested by the Chief Technical Officer at a price of $1.13 per share. As a result of the transaction, LEE ANN L. now holds 100,000 shares, worth roughly $0.15 million.
Citigroup downgraded its Prime Medicine Inc [PRME] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in mid May from “an Overweight” to “a Neutral”. H.C. Wainwright also remained covering PRME and has decreased its forecast on May 20, 2025 with a “Neutral” recommendation from previously “Buy” rating. JMP Securities started covering the stock on December 10, 2024. It rated PRME as “a Mkt outperform”.
Price Performance Review of PRME
On Friday, Prime Medicine Inc [NASDAQ:PRME] saw its stock unchanged to $1.46. Over the last five days, the stock has lost -13.61%. Prime Medicine Inc shares have fallen nearly -50.00% since the year began. Nevertheless, the stocks have fallen -80.32% over the past one year. While a 52-week high of $8.07 was reached on 01/06/25, a 52-week low of $1.11 was recorded on 05/22/25.
Levels Of Support And Resistance For PRME Stock
The 24-hour chart illustrates a support level at 1.4033, which if violated will result in even more drops to 1.3467. On the upside, there is a resistance level at 1.5133. A further resistance level may holdings at 1.5667.
How much short interest is there in Prime Medicine Inc?
A steep rise in short interest was recorded in Prime Medicine Inc stocks on 2025-05-30, growing by 1.44 million shares to a total of 17.97 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 16.53 million shares. There was a rise of 8.01%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on May 20, 2024 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $10 price target.
